{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:31:04Z","timestamp":1775845864188,"version":"3.50.1"},"reference-count":56,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.5551\/jat.62851","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T22:07:36Z","timestamp":1626905256000},"page":"937-952","source":"Crossref","is-referenced-by-count":5,"title":["Beta-2-Microglobulin is an Independent Risk Factor for Asymptomatic Carotid Atherosclerosis in Patients with Primary Aldosteronism"],"prefix":"10.5551","volume":"29","author":[{"given":"Shangyan","family":"Liang","sequence":"first","affiliation":[{"name":"Department of VIP Medical Service Center, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of VIP Medical Service Center, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianwei","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of VIP Medical Service Center, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of VIP Medical Service Center, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xubin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, the 3rd Affiliated Hospital of Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Jr., Montori VM and Endocrine S: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocr Metab, 2008; 93: 3266-3281","DOI":"10.1210\/jc.2008-0104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M and Young WF, Jr.: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocr Metab, 2016; 101: 1889-1916","DOI":"10.1210\/jc.2015-4061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Calhoun DA: Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension, 2007; 50: 447-453; discussion 447-453","DOI":"10.1161\/HYPERTENSIONAHA.106.086116"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Young MJ and Funder JW: Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens, 2002; 20: 1465-1468","DOI":"10.1097\/00004872-200208000-00002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Rocha R and Stier CT, Jr.: Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab, 2001; 12: 308-314","DOI":"10.1016\/S1043-2760(01)00432-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F and Veglio F: Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism. J Clin Endocr Metab, 2013; 98: 4826-4833","DOI":"10.1210\/jc.2013-2805"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Muth A, Ragnarsson O, Johannsson G and Wangberg B: Systematic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg, 2015; 102: 307-317","DOI":"10.1002\/bjs.9744"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH and Cushman M: Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation, 2007; 116: 32-38","DOI":"10.1161\/CIRCULATIONAHA.106.645606"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Murray CSG, Nahar T, Kalashyan H, Becher H and Nanda NC: Ultrasound assessment of carotid arteries: Current concepts, methodologies, diagnostic criteria, and technological advancements. Echocardiography (Mount Kisco, NY), 2018; 35: 2079-2091","DOI":"10.1111\/echo.14197"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V and Desormais I: 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J, 2018; 39: 3021-3104","DOI":"10.1201\/9780429199189-75"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jovanovic D, Krstivojevic P, Obradovic I, Durdevic V and Dukanovic L: Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail, 2003; 25: 123-133","DOI":"10.1081\/JDI-120017475"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J and Levey AS: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med, 2012; 367: 20-29","DOI":"10.1056\/NEJMoa1114248"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zumrutdal A, Sezer S, Demircan S, Seydaoglu G, Ozdemir FN and Haberal M: Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis. Nephrology, 2005; 10: 453-458","DOI":"10.1111\/j.1440-1797.2005.00475.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kim MK, Yun KJ, Chun HJ, Jang EH, Han KD, Park YM, Baek KH, Song KH, Cha BY, Park CS and Kwon HS: Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment. Diabetes Metab, 2014; 40: 459-465","DOI":"10.1016\/j.diabet.2014.08.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Huang R, Gu J, Cao Q, Ma J, Gu W and Fan Z: The association between serum cystatin C and carotid intima\u2013media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate. Clin Chim Acta, 2015; 448: 170-173","DOI":"10.1016\/j.cca.2015.07.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kobayashi T, Yokokawa H, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H and Naito T: Association between high cystatin C levels and carotid atherosclerosis. World J Cardiol, 2017; 9: 174-181","DOI":"10.4330\/wjc.v9.i2.174"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) You L, Xie R, Hu H, Gu G, Zheng H, Zhang J, Yang X, He X and Cui W: High levels of serum beta2-microglobulin predict severity of coronary artery disease. BMC Cardiovasc Disord, 2017; 17: 71","DOI":"10.1186\/s12872-017-0502-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Patel D, Ahmad S, Silverman A and Lindsay J: Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women\u2019s Angiographic Vitamin and Estrogen [WAVE] study). Am J Cardiol, 2013; 111: 1681-1687","DOI":"10.1016\/j.amjcard.2013.02.019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY, Zhang F, Beck KR, Olin JW, Fung ET and Cooke JP: Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation, 2007; 116: 1396-1403","DOI":"10.1161\/CIRCULATIONAHA.106.683722"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shinkai S, Chaves PH, Fujiwara Y, Watanabe S, Shibata H, Yoshida H and Suzuki T: Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch Intern Med, 2008; 168: 200-206","DOI":"10.1001\/archinternmed.2007.64"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP and Coresh J: Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis, 2013; 62: 42-51","DOI":"10.1053\/j.ajkd.2013.01.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Naqvi TZ and Lee MS: Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging, 2014; 7: 1025-1038","DOI":"10.1016\/j.jcmg.2013.11.014"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, Gocke J, Hertzberg BS, Katarick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler E and Society of Radiologists in U: Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis--Society of Radiologists in Ultrasound consensus conference. Ultrasound Q, 2003; 19: 190-198","DOI":"10.1097\/00013644-200312000-00005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Bothou C, Beuschlein F and Spyroglou A: Links between aldosterone excess and metabolic complications: A comprehensive review. Diabetes Metab, 2020; 46: 1-7","DOI":"10.1016\/j.diabet.2019.02.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Halimi JM and Mimran A: Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens, 1995; 13: 1801-1802","DOI":"10.1097\/00004872-199512010-00054"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chen ZW, Tsai CH, Pan CT, Chou CH, Liao CW, Hung CS, Wu VC and Lin YH: Endothelial Dysfunction in Primary Aldosteronism. Int J Mol Sci, 2019; 20:","DOI":"10.3390\/ijms20205214"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, Agostoni P, Voskuil M, Ivanes F, Jude B, Bertrand ME, Pasterkamp G, van der Graaf Y, Doevendans PA, Montalescot G and Van Belle E: Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data. Am Heart J, 2011; 162: 585-596","DOI":"10.1016\/j.ahj.2011.06.015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ambrosino P, Lupoli R, Tortora A, Cacciapuoti M, Lupoli GA, Tarantino P, Nasto A and Di Minno MND: Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies. Int J Cardiol, 2016; 208: 46-55","DOI":"10.1016\/j.ijcard.2016.01.200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Baldassarre D, Amato M, Bondioli A, Sirtori CR and Tremoli E: Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke, 2000; 31: 2426-2430","DOI":"10.1161\/01.STR.31.10.2426"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Inaba Y, Chen JA and Bergmann SR: Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis, 2012; 220: 128-133","DOI":"10.1016\/j.atherosclerosis.2011.06.044"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tada H, Nakagawa T, Okada H, Nakahashi T, Mori M, Sakata K, Nohara A, Takamura M and Kawashiri MA: Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events. J Atheroscler Thromb, 2020; 27: 38-46","DOI":"10.5551\/jat.49551"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Su TC, Jeng JS, Chien KL, Sung FC, Hsu HC and Lee YT: Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke, 2001; 32: 2265-2271","DOI":"10.1161\/str.32.10.2265"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, Quinkler M, Hanslik G, Lang K, Hahner S, Allolio B, Meisinger C, Holle R, Beuschlein F, Bidlingmaier M, Endres S and German Conn\u2019s Registry-Else Kroner-Fresenius-Hyperaldosteronism R: Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension, 2012; 60: 618-624","DOI":"10.1161\/HYPERTENSIONAHA.112.197111"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Stehr CB, Mellado R, Ocaranza MP, Carvajal CA, Mosso L, Becerra E, Solis M, Garcia L, Lavandero S, Jalil J and Fardella CE: Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens, 2010; 28: 2120-2126","DOI":"10.1097\/HJH.0b013e32833d0177"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Widimsky J, Jr., Strauch B, Petrak O, Rosa J, Somloova Z, Zelinka T and Holaj R: Vascular disturbances in primary aldosteronism: clinical evidence. Kidney Blood Press Res, 2012; 35: 529-533","DOI":"10.1159\/000340031"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM and Agabiti-Rosei E: Vascular hypertrophy and remodeling in secondary hypertension. Hypertension, 1996; 28: 785-790","DOI":"10.1161\/01.HYP.28.5.785"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Lin Y-H, Lin L-Y, Chen A, Wu X-M, Lee J-K, Su T-C, Wu V-C, Chueh S-C, Lin W-C, Lo M-T, Wang P-C, Ho Y-L and Wu K-D: Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis, 2012; 221: 154-159","DOI":"10.1016\/j.atherosclerosis.2011.12.003"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Matsuda Y, Kawate H, Matsuzaki C, Sakamoto R, Shibue K, Ohnaka K, Anzai K, Nomura M and Takayanagi R: Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism. Endocr J, 2016; 63: 249-255","DOI":"10.1507\/endocrj.EJ15-0362"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Holaj R, Rosa J, Zelinka T, Strauch B, Petrak O, Indra T, Somloova Z, Michalsky D, Novak K, Wichterle D and Widimsky J, Jr.: Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness. J Hypertens, 2015; 33: 874-882; discussion 882","DOI":"10.1097\/HJH.0000000000000464"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Takayama F, Miyazaki S, Morita T, Hirasawa Y and Niwa T: Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl, 2001; 78: S172-176","DOI":"10.1046\/j.1523-1755.2001.07835.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC and Frangione B: Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest, 1985; 76: 2425-2429","DOI":"10.1172\/JCI112257"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, Timmel E, Kickinger B, Minar C, Pones M, Lalouschek W, Rumpold H, Maurer G, Wagner O and Minar E: Inflammation and Carotid Artery\u2014Risk for Atherosclerosis Study (ICARAS). Circulation, 2005; 111: 2203-2209","DOI":"10.1161\/01.CIR.0000163569.97918.C0"},{"key":"43","unstructured":"43) Forman DT: Beta-2 microglobulin--an immunogenetic marker of inflammatory and malignant origin. Ann Clin Lab Sci, 1982; 12: 447-452"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Brusic V and Petrovsky N: Bioinformatics for characterisation of allergens, allergenicity and allergic crossreactivity. Trends Immunol, 2003; 24: 225-228","DOI":"10.1016\/S1471-4906(03)00075-9"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Himmelfarb J: Linking oxidative stress and inflammation in kidney disease: Which is the chicken and which is the egg? Semin Dialysis, 2004; 17: 449-454","DOI":"10.1111\/j.0894-0959.2004.17605.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V and Vlassopoulos D: Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs, 2009; 32: 872-882","DOI":"10.1177\/039139880903201206"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y and Schmidt AM: The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest, 1996; 98: 1088-1094","DOI":"10.1172\/JCI118889"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) McCurley A and Jaffe IZ: Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol, 2012; 350: 256-265","DOI":"10.1016\/j.mce.2011.06.014"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL and Touyz RM: c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension, 2005; 46: 1032-1038","DOI":"10.1161\/01.HYP.0000176588.51027.35"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Rafiq K, Hitomi H, Nakano D and Nishiyama A: Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney. J Pharmacol Sci, 2011; 115: 1-7","DOI":"10.1254\/jphs.10R07CR"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Nishiyama A and Kobori H: Independent regulation of renin-angiotensin-aldosterone system in the kidney. Clin Exp Nephrol, 2018; 22: 1231-1239","DOI":"10.1007\/s10157-018-1567-1"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Jernberg T, Lindahl B, James S, Larsson A, Hansson LO and Wallentin L: Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation, 2004; 110: 2342-2348","DOI":"10.1161\/01.CIR.0000145166.44942.E0"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P and Group PS: Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis, 2006; 185: 375-380","DOI":"10.1016\/j.atherosclerosis.2005.06.017"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Albert MA, Rifai N and Ridker PM: Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med, 2001; 6: 145-149","DOI":"10.1177\/1358836X0100600304"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Eriksson P, Deguchi H, Samneg\u00e5rd A, Lundman P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S and Hamsten A: Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol, 2004; 24: 551-557","DOI":"10.1161\/01.ATV.0000117180.57731.36"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, Fang K, Chapman HA and Shi GP: Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res, 2005; 96: 368-375","DOI":"10.1161\/01.RES.0000155964.34150.F7"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/6\/29_62851\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T05:02:02Z","timestamp":1654318922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/6\/29_62851\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.62851","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"62851"}}